Molecular profiling of small renal masses: Current status and future directions.
Small renal masses (SRMs) are renal tumors less than 4 cm in diameter. These account for the largest proportion of newly diagnosed renal cell cancers (RCC). Management of SRMs can be a dilemma if the patient is unfit to undergo partial nephrectomy. Molecular profiling enables better characterization of RCC and prediction of outcomes in terms of recurrence and progression. This article reviews the existing literature on molecular profiling of localized RCC, discusses limitations of molecular profiling, and presents the likely role that molecular profiling will play in guiding the treatment of SRMs.
Kalyanaraman
Balaji
B
Division of Urology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Gaitonde
Krishnanath
K
Donovan
James F
JF